HAE
HAE
NYSE · Health Care

Haemonetics Corp/Mass

$87.84
+2.82 (+3.32%)
As of Aug 8, 10:00 PM ET ·
Financial Highlights (FY 2026)
Revenue
1.24B
Net Income
90.78M
Gross Margin
59.0%
Profit Margin
7.3%
Rev Growth
+4.5%
D/E Ratio
1.54
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 59.0% 59.0% 54.3% 54.3%
Operating Margin 11.7% 10.6% 11.5% 11.0%
Profit Margin 7.3% 6.9% 7.9% 6.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 1.24B 1.19B 2.17B 1.94B
Gross Profit 734.30M 702.61M 1.18B 1.05B
Operating Income 146.24M 125.93M 248.79M 212.97M
Net Income 90.78M 78.18M 171.22M 125.72M
Gross Margin 59.0% 59.0% 54.3% 54.3%
Operating Margin 11.7% 10.6% 11.5% 11.0%
Profit Margin 7.3% 6.9% 7.9% 6.5%
Rev Growth +4.5% +4.5% +24.6% +5.9%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 1.18B 1.18B 666.77M 805.22M
Total Equity 764.57M 764.57M 1.73B 1.53B
D/E Ratio 1.54 1.54 0.39 0.53
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 187.27M 170.23M 302.84M 250.08M
Free Cash Flow 163.13M 182.49M